LifeVantage Declares Quarterly Dividend

SALT LAKE CITY, Aug. 21, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.050 per share of common stock, which will be paid September 15, 2026 to all stockholders of record at the close of business on September 1, 2026.

GlobeNewsWire • Aug 21, 2026

LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2026 Results on August 27, 2026

SALT LAKE CITY, Aug. 13, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its fourth quarter and full fiscal year ended June 30, 2026, after the stock market closes on Thursday, August 27, 2026. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.

GlobeNewsWire • Aug 13, 2026

LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SALT LAKE CITY, Aug. 11, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”) today announced that its Board of Directors granted inducement awards to Terrence Moorehead, the Company's new President and Chief Executive Officer, under the Company's 2026 New Employee Long-Term Incentive Plan (the “New Employee Plan”) as an inducement material to Mr. Moorehead's employment in accordance with Nasdaq Listing Rule 5635(c)(4).

GlobeNewsWire • Aug 11, 2026

LifeVantage Welcomes Terrence Moorehead as Chief Executive Officer

SALT LAKE CITY, Aug. 05, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced Terrence Moorehead has officially joined the Company as President and Chief Executive Officer and as a member of the Board of Directors. Moorehead's appointment was previously announced on April 16, 2026.

GlobeNewsWire • Aug 5, 2026

Do Options Traders Know Something About LifeVantage Stock We Don't?

Investors need to pay close attention to LFVN stock based on the movements in the options market lately.

Zacks Investment Research • May 27, 2026

LifeVantage Corporation (LFVN) Q3 2026 Earnings Call Transcript

LifeVantage Corporation (LFVN) Q3 2026 Earnings Call Transcript

Seeking Alpha • May 7, 2026

LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2026

SALT LAKE CITY, May 06, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2026. Third Quarter Fiscal 2026 Summary*: Revenue was $43.7 million, a decrease of 25.2% from the prior year period; Revenue in the Americas decreased 28.9%, and revenue in Asia/Pacific & Europe decreased 7.7%; Net income per diluted share was $0.11, versus $0.26 per diluted share a year ago; Adjusted earnings per diluted share was $0.12, compared to $0.26 a year ago; and Adjusted EBITDA was $3.2 million compared to $6.4 million a year ago.

GlobeNewsWire • May 6, 2026

Lifevantage (LFVN) Q3 Earnings and Revenues Miss Estimates

Lifevantage (LFVN) came out with quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.26 per share a year ago.

Zacks Investment Research • May 6, 2026

Strength Seen in Lifevantage (LFVN): Can Its 8.5% Jump Turn into More Strength?

Lifevantage (LFVN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks Investment Research • Apr 28, 2026

LifeVantage to Announce Third Quarter Fiscal Year 2026 Results on May 6, 2026

SALT LAKE CITY, April 22, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its third quarter ended March 31, 2026, after the stock market closes on Wednesday, May 6, 2026. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.

GlobeNewsWire • Apr 22, 2026